FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

21994811000001105: Lixisenatide 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devices (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 06-Mar 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
72994801000001117 Lixisenatide 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devices (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
72994901000001111 Lixisenatide 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devices en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lixisenatide 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devices Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route solutioninjection.subcutaneous ontology form and route true Inferred relationship Existential restriction modifier
Lixisenatide 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devices Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Lixisenatide 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devices Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lixisenatide 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devices Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Subcutaneous route true Inferred relationship Existential restriction modifier
Lixisenatide 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devices Is a Lixisenatide true Inferred relationship Existential restriction modifier
Lixisenatide 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devices Has dispensed dose form Conventional release solution for injection true Inferred relationship Existential restriction modifier
Lixisenatide 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devices Has specific active ingredient Lixisenatide false Inferred relationship Existential restriction modifier
Lixisenatide 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devices VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lixisenatide 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devices VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lixisenatide 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devices Is a Lixisenatide false Inferred relationship Existential restriction modifier
Lixisenatide 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devices Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Lixisenatide 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devices Has specific active ingredient Lixisenatide true Inferred relationship Existential restriction modifier
Lixisenatide 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devices Has manufactured dose form Conventional release solution for injection false Inferred relationship Existential restriction modifier
Lixisenatide 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devices Has active ingredient Substance with glucagon-like peptide 1 receptor agonist mechanism of action (substance) false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Lyxumia 20micrograms/0.2ml solution for injection 3ml pre-filled pens (Sanofi) Is a True Lixisenatide 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devices Inferred relationship Existential restriction modifier
Lixisenatide 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devices 1 pre-filled disposable injection Has VMP True Lixisenatide 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devices Inferred relationship Existential restriction modifier
Lixisenatide 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devices 2 pre-filled disposable injection Has VMP True Lixisenatide 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devices Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start